TP53 mutations in nonsmall cell lung cancer

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Mogi, Akira ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BLOOD GROUP A ANTIGEN; CARBOPLATIN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ETOPOSIDE; K RAS PROTEIN; MUCIN; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; TOBACCO SMOKE; TP53 PROTEIN, HUMAN;

ADVANCED CANCER; BRONCHUS CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DELETION MUTANT; DISTANT METASTASIS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INACTIVATION; GENE MUTATION; GENE REPLACEMENT THERAPY; HUMAN; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MOLECULAR PATHOLOGY; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL RATE; TREATMENT PLANNING; VIRAL GENE DELIVERY SYSTEM; WILD TYPE; GENETICS; LUNG TUMOR; MUTATION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952209189     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/583929     Document Type: Review

References (106)

1. Lane D. P., Crawford L. V., T antigen is bound to a host protein in SV40 transf (Pubitemid 9129076)
2. Linzer D. I. H., Levine A. J., Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells Cell 1979 17 1 43 52 (Pubitemid 9188209)
3. Kress M., May E., Cassingena R., May P., Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum Journal of Virology 1979 31 2 472 483 (Pubitemid 9233894)
4. Melero J. A., Stitt D. T., Mangel W. F., Carroll R. B., Identification of new polypeptide species (48-55K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells Virology 1979 93 2 466 480 (Pubitemid 9145500)
5. Munro A. J., Lain S., Lane D. P., P53 abnormalities and outcomes in colorectal cancer: a systematic review British Journal of Cancer 2005 92 3 434 444 (Pubitemid 40395523)
6. Vogelstein B., Lane D., Levine A. J., Surfing the p53 network Nature 2000 16 307 310
7. Vousden K. H., Lu X., Live or let die: the cell's response to p53 Nature Reviews Cancer 2002 2 8 594 604 (Pubitemid 37328926)
8. McKinney C., Prives C., Regulation of p53 DNA Binding. 25 Years of p53 Research 2005 Dordrecht, The Netherlands Springer
9. Levine A. J., p53, the cellular gatekeeper for growth and division Cell 1997 88 3 323 331 (Pubitemid 27131374)
10. Jin S., Levine A. J., The p53 functional circuit Journal of Cell Science 2001 114 23 4139 4140 (Pubitemid 33138651)
11. Riley T., Sontag E., Chen P., Levine A., Transcriptional control of human p53-regulated genes Nature Reviews Molecular Cell Biology 2008 9 5 402 412 (Pubitemid 351574202)
12. Pomerantz J., Schreiber-Agus N., Ligeois N. J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H. W., Cordon-Cardo C., DePinho R. A., The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53 Cell 1998 92 6 713 723 (Pubitemid 28155311)
13. Zhang Y., Xiong Y., Yarbrough W. G., ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 1998 92 6 725 734 (Pubitemid 28155312)
14. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002 CA:A Cancer Journal for Clinicians 2005 55 2 74 108 (Pubitemid 40372904)
15. Bodner S. M., Minna J. D., Jensen S. M., D'Amico D., Carbone D., Mitsudomi T., Fedorko J., Buchhagen D. L., Nau M. M., Gazdar A. F., Linnoila R. I., Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation Oncogene 1992 7 4 743 749
16. Takahashi T., Nau M. M., Chiba I., Birrer M. J., Rosenberg R. K., Vinocour M., Levitt M., Pass H., Gazdar A. D., Minna J. D., p53: a frequent target for genetic abnormalities in lung cancer Science 1989 246 4929 491 494 (Pubitemid 19273938)
17. Hainaut P., Soussi T., Shomer B., Hollstein M., Greenblatt M., Hovig E., Harris C. C., Montesano R., Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects Nucleic Acids Research 1997 25 1 151 157 (Pubitemid 27303173)
18. Hainaut P., Wiman K. G., 30 years and a long way into p53 research The Lancet Oncology 2009 10 9 913 919
19. Hofseth L. J., Hussain S. P., Harris C. C., p53: 25 Years after its discovery Trends in Pharmacological Sciences 2004 25 4 177 181 (Pubitemid 38519907)
20. Olivier M., Hussain S. P., Caron de Fromentel C., Hainaut P., Harris C. C., TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer IARC Scientific Publications 2004 157 247 270
21. Soussi T., Ishioka C., Claustres M., Broud C., Locus-specific mutation databases: pitfalls and good practice based on the p53 experience Nature Reviews Cancer 2006 6 1 83 90 (Pubitemid 43053654)
22. Olivier M., Hollstein M., Hainaut P., TP53 mutations in human cancers: origins, consequences, and clinical use Cold Spring Harbor Perspectives in Biology 2010 2 1
23. Robles A. I., Harris C. C., Clinical outcomes and correlates of TP53 mutations and cancer Cold Spring Harbor perspectives in biology 2010 2 3
24. Soussi T., The p53 pathway and human cancer British Journal of Surgery 2005 92 11 1331 1332 (Pubitemid 41546627)
25. Olivier M., Eeles R., Hollstein M., Khan M. A., Harris C. C., Hainaut P., The IARC TP53 database: new online mutation analysis and recommendations to users Human Mutation 2002 19 6 607 614 (Pubitemid 34556481)
26. Hollstein M., Sidransky D., Vogelstein B., Harris C. C., p53 Mutations in human cancers Science 1991 253 5015 49 53 (Pubitemid 21917115)
27. Petitjean A., Mathe E., Kato S., Ishioka C., Tavtigian S. V., Hainaut P., Olivier M., Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database Human Mutation 2007 28 6 622 629 (Pubitemid 46744292)
28. Li F. P., Fraumeni J. F., Mulvihill J. J., Blattner W. A., Dreyfus M. G., Tucker M. A., Miller R. W., A cancer family syndrome in twenty-four kindreds Cancer Research 1988 48 18 5358 5362
29. Srivastava S., Zou Z., Pirollo K., Blattner W., Chang E. H., Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome Nature 1990 348 6303 747 749 (Pubitemid 120015153)
30. Olivier M., Goldgar D. E., Sodha N., Ohgaki H., Kleihues P., Hainaut P., Eeles R. A., Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype Cancer Research 2003 63 20 6643 6650 (Pubitemid 37322942)
31. Ory K., Legros Y., Auguin C., Soussi T., Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation EMBO Journal 1994 13 15 3496 3504 (Pubitemid 24246186)
32. Sigal A., Rotter V., Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome Cancer Research 2000 60 24 6788 6793 (Pubitemid 32059139)
33. Peart M. J., Prives C., Mutant p53 gain of function: the NF-Y connection Cancer Cell 2006 10 3 173 174 (Pubitemid 44311071)
34. Petitjean A., Achatz M. I. W., Borresen-Dale A. L., Hainaut P., Olivier M., TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes Oncogene 2007 26 15 2157 2165 (Pubitemid 46536647)
35. Song H., Xu Y., Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways Cell Cycle 2007 6 13 1570 1573 (Pubitemid 47327942)
36. Donzelli S., Biagioni F., Fausti F., Strano S., Fontemaggi G., Blandino G., Oncogenomic approaches in exploring gain of function of mutant p53 Current Genomics 2008 9 3 200 207 (Pubitemid 351895023)
37. Brosh R., Rotter V., When mutants gain new powers: news from the mutant p53 field Nature Reviews Cancer 2009 9 10 701 713
38. Goldstein I., Marcel V., Olivier M., Oren M., Rotter V., Hainaut P., Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies Cancer Gene Therapy 2010 18 1 2 11
39. Pfeifer G. P., Besaratinia A., Mutational spectra of human cancer Human Genetics 2009 125 5-6 493 506
40. Hinds P. W., Finlay C. A., Quartin R. S., Baker S. J., Fearon E. R., Vogelstein B., Levine A. J., Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes Cell Growth amp; Differentiation 1990 1 12 571 580
41. Hainaut P., Hollstein M., p53 and human cancer: the first ten thousand mutations Advances in Cancer Research 2000 77 81 137 (Pubitemid 29439303)
42. Pfeifer G. P., Denissenko M. F., Olivier M., Tretyakova N., Hecht S. S., Hainaut P., Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene 2002 21 48 7435 7451 (Pubitemid 35305599)
43. Perwez Hussain S., Hollstein M. H., Harris C. C., p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment Annals of the New York Academy of Sciences 2000 919 79 85
44. Hainaut P., Pfeifer G. P., Patterns of p53→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis 2001 22 3 367 374 (Pubitemid 32203813)
45. Baumann M., Zips D., Appold S., Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity Radiotherapy and Oncology 2009 91 3 279 281
46. Viktorsson K., De Petris L., Lewensohn R., The role of p53 in treatment responses of lung cancer Biochemical and Biophysical Research Communications 2005 331 3 868 880 (Pubitemid 40615518)
47. Steels E., Paesmans M., Berghmans T., Branle F., Lemaitre F., Mascaux C., Meert A. P., Vallot F., Lafitte J. J., Sculier J. P., Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis European Respiratory Journal 2001 18 4 705 719 (Pubitemid 33040631)
48. Takahashi T., Takahashi T., Suzuki H., Hida T., Sekido Y., Ariyoshi Y., Ueda R., The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern Oncogene 1991 6 10 1775 1778 (Pubitemid 21924008)
49. Hensel C. H., Xiang R. H., Sagaguchi A. Y., Naylor S. L., Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer Oncogene 1991 6 6 1067 1071 (Pubitemid 21924188)
50. Sameshima Y., Matsuno Y., Hirohashi S., Shimosato Y., Mizoguchi H., Sugimura T., Terada M., Yokota J., Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma Oncogene 1992 7 3 451 457
51. D'Amico D., Carbone D., Mitsudomi T., Nau M., Fedorko J., Russell E., Johnson B., Buchhagen D., Bodner S., Phelps R., Gazdar A., Minna J. D., High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors Oncogene 1992 7 2 339 346
52. Kishimoto Y., Murakami Y., Shiraishi M., Hayashi K., Sekiya T., Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung Cancer Research 1992 52 17 4799 4804
53. Tammemagi M. C., McLaughlin J. R., Bull S. B., Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers Cancer Epidemiology Biomarkers and Prevention 1999 8 7 625 634 (Pubitemid 29337324)
54. Reichel M. B., Ohgaki H., Petersen I., Kleihues P., p53 mutations in primary human lung tumors and their metastases Molecular Carcinogenesis 1994 9 2 105 109 (Pubitemid 24099081)
55. Miller C. W., Simon K., Aslo A., Kok K., Yokota J., Buys C. H. C. M., Terada M., Koeffler H. P., p53 Mutations in human lung tumors Cancer Research 1992 52 7 1695 1698
56. Chiba I., Takahashi T., Nau M. M., D'Amico D., Curiel D. T., Mitsudomi T., Buchhagen D. L., Carbone D., Piantadosi S., Koga H., Reissman P. T., Slamon D. J., Holmes E. C., Minna J. D., Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer Oncogene 1990 5 10 1603 1610
57. Sozzi G., Miozzo M., Pastorino U., Pilotti S., Donghi R., Giarola M., De Gregorio L., Manenti G., Radice P., Minoletti F., Della Porta G., Pierotti M. A., Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions Cancer Research 1995 55 1 135 140
58. Harris C. C., p53 tumor suppressor gene: from the basic research laboratory to the clinican abridged historical perspective Carcinogenesis 1996 17 6 1187 1198 (Pubitemid 26196329)
59. Chang Y.-L., Wu C.-T., Shih J.-Y., Lee Y.-C., Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers. Annals of Surgical Oncology. In press
60. Mitsudomi T., Hamajima N., Ogawa M., Takahashi T., Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis Clinical Cancer Research 2000 6 10 4055 4063
61. Graziano S. L., Gu L., Wang X., Tatum A. H., Vollmer R. T., Strauss G. M., Kratzke R., Dudek A. Z., Vokes E. E., Green M. R., Prognostic significance of mucin and P53 expression in stage ib non-small cell lung cancer: a laboratory companion study to CALGB 9633 Journal of Thoracic Oncology 2010 5 6 810 817
62. Tsao M. S., Aviel-Ronen S., Ding K., Lau D., Liu NI., Sakurada A., Whitehead M., Zhu C. Q., Livingston R., Johnson D. H., Rigas J., Seymour L., Winton T., Shepherd F. A., Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small-cell lung cancer Journal of Clinical Oncology 2007 25 33 5240 5247 (Pubitemid 350232256)
63. Custodio A. B., Gonzlez-Larriba J. L., Bobokova J., Calles A., lvarez R., Cuadrado E., Manzano A., Daz-Rubio E., Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer Journal of Thoracic Oncology 2009 4 7 891 910
64. Kandioler D., Stamatis G., Eberhardt W., Kappel S., Zchbauer-Mller S., Khrer I., Mittlbck M., Zwrtek R., Aigner C., Bichler C., Tichy V., Hudec M., Bachleitner T., End A., Mller M. R., Roth E., Klepetko W., Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer Journal of Thoracic and Cardiovascular Surgery 2008 135 5 1036 1041 (Pubitemid 351622069)
65. Doll R., Hill A. B., Mortality in relation to smoking ten years observations of British doctors British Medical Journal 1964 1 5396 1460 1467
66. Hecht S. S., Progress and challenges in selected areas of tobacco carcinogenesis Chemical Research in Toxicology 2008 21 1 160 171 (Pubitemid 351219717)
67. Koo L. C., Ho J. H. C., Worldwide epidemiological patterns of lung cancer in nonsmokers International Journal of Epidemiology 1990 19 1 S14 S23
68. Tyczynski J. E., Bray F., Parkin D. M., Lung cancer in Europe in 2000: epidemiology, prevention, and early detection Lancet Oncology 2003 4 1 45 55 (Pubitemid 36124190)
69. Tyczynski J. E., Bray F., Aareleid T., Dalmas M., Kurtinaitis J., Plesko I., Pompe-Kirn V., Stengrevics A., Parkin D. M., Lung cancer mortality patterns in selected Central, Eastern and Southern European countries International Journal of Cancer 2004 109 4 598 610 (Pubitemid 38339652)
70. Tyczynski J. E., Berkel H. J., Mortality from lung cancer and tobacco smoking in Ohio (U.S.): will increasing smoking prevalence reverse current decreases in mortality? Cancer Epidemiology Biomarkers and Prevention 2005 14 5 1182 1187 (Pubitemid 40656464)
71. Bennett W. P., Alavanja M. C. R., Blomeke B., Vhkangas K. H., Castrn K., Welsh J. A., Bowman E. D., Khan M. A., Flieder D. B., Harris C. C., Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women Journal of the National Cancer Institute 1999 91 23 2009 2014
72. Husgafvel-Pursiainen K., Boffetta P., Kannio A., Nyberg F., Pershagen G., Mukeria A., Constantinescu V., Fortes C., Benhamou S., p53 Mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer Cancer Research 2000 60 11 2906 2911 (Pubitemid 30395814)
73. Takagi Y., Osada H., Kuroishi T., Mitsudomi T., Kondo M., Niimi T., Saji S., Gazdar A. F., Takahashi T., Minna J. D., Takahashi T., p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking British Journal of Cancer 1998 77 10 1568 1572 (Pubitemid 28230455)
74. Vhkangas K. H., Bennett W. P., Castrn K., Welsh J. A., Khan M. A., Blmeke B., Alavanja M. C. R., Harris C. C., p53 and K-ras mutations in lung cancers from former and never-smoking women Cancer Research 2001 61 11 4350 4356 (Pubitemid 32685758)
75. Hainaut P., Olivier M., Pfeifer G. P., TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database Mutagenesis 2001 16 551 553 (Pubitemid 33069649)
76. Hussain S. P., Harris C. C., Molecular epidemiology of human cancer Recent Results in Cancer Research 1998 154 22 36
77. Toyooka S., Tsuda T., Gazdar A. F., The TP53 gene, tobacco exposure, and lung cancer Human Mutation 2003 21 3 229 239 (Pubitemid 36292965)
78. Ding L., Getz G., Wheeler D. A., Somatic mutations affect key pathways in lung adenocar Nature 2008 455 1069 1075
79. Denissenko M. F., Pao A., Tang M. S., Pfeifer G. P., Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53 Science 1996 274 5286 430 432 (Pubitemid 26353359)
80. Smith L. E., Denissenko M. F., Bennett W. P., Li H., Amin S., Tang M. S., Pfeifer G. P., Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons Journal of the National Cancer Institute 2000 92 10 803 811 (Pubitemid 30368036)
81. Denissenko M. F., Koudriakova T. B., Smith L., O'Connor T. R., Riggs A. D., Pfeifer G. P., The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B adducts Oncogene 1998 17 23 3007 3014 (Pubitemid 29012203)
82. Hernandez-Boussard T. M., Hainaut P., A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database Environmental Health Perspectives 1998 106 7 385 391 (Pubitemid 28524103)
83. Gealy R., Zhang L., Siegfried J. M., Luketich J. D., Keohavong P., Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women Cancer Epidemiology Biomarkers and Prevention 1999 8 297 302 (Pubitemid 29193900)
84. Kondo K., Tsuzuki H., Sasa M., Sumitomo M., Uyama T., Monden Y., A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients Journal of Surgical Oncology 1996 61 1 20 26 (Pubitemid 26025123)
85. Subramanian J., Govindan R., Molecular genetics of lung cancer in people who have never smoked The Lancet Oncology 2008 9 7 676 682 (Pubitemid 351878053)
86. Gow C. H., Chang Y. L., Hsu Y. C., Tsai M. F., Wu C. T., Yu C. J., Yang C. H., Lee Y. C., Yang P. C., Shih J. Y., Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Annals of Oncology 2009 20 4 696 702
87. Fujiwara T., Grimm E. A., Mukhopadhyay T., Zhang W. W., Owen-Schaub L. B., Roth J. A., Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene Cancer Research 1994 54 9 2287 2291 (Pubitemid 24138709)
88. Higashiyama M., Kodama K., Yokouchi H., Takami K., Doi O., Kobayashi H., Tanisaka K., Minamigawa K., Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs Journal of Surgical Oncology 1998 68 1 19 24 (Pubitemid 28243863)
89. Rusch V., Klimstra D., Venkatraman E., Oliver J., Martini N., Gralla R., Kris M., Dmitrovsky E., Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer Cancer Research 1995 55 21 5038 5042
90. Vogt U., Zaczek A., Klinke F., Granetzny A., Bielawski K., Falkiewicz B., p53 gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer Journal of Cancer Research and Clinical Oncology 2002 128 3 141 147 (Pubitemid 34185636)
91. Leslie W. T., Bonomi P. D., Novel treatments in non-small cell lung cancer Hematology/Oncology Clinics of North America 2004 18 1 245 267 (Pubitemid 38201559)
92. Fujiwara T., De Wei Cai, Georges R. N., Mukhopadhyay T., Crimm E. A., Roth J. A., Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model Journal of the National Cancer Institute 1994 86 19 1458 1462 (Pubitemid 24317587)
93. Roth J. A., Nguyen D., Lawrence D. D., Kemp B. L., Carrasco C. H., Ferson D. Z., Hong W. K., Komaki R., Lee J. J., Nesbitt J. C., Pisters K. M. W., Putnam J. B., Schea R., Shin D. M., Walsh G. L., Dolormente M. M., Han C. I., Martin F. D., Yen N., Xu K., Stephens L. C., Mcdonnell T. J., Mukhopadhyay T., Cai D., Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer Nature Medicine 1996 2 9 985 991 (Pubitemid 26306836)
94. Wiman K. G., Strategies for therapeutic targeting of the p53 pathway in cancer Cell Death and Differentiation 2006 13 6 921 926
95. Swisher S. G., Roth J. A., Nemunaitis J., Lawrence D. D., Kemp B. L., Carrasco C. H., Connors D. G., El-Naggar A. K., Fossella F., Glisson B. S., Hong W. K., Khuri F. R., Kurie J. M., Lee J. J., Lee J. S., Mack M., Merritt J. A., Nguyen D. M., Nesbitt J. C., Perez-Soler R., Pisters K. M. W., Putnam J. B., Richli W. R., Savin M., Schrump D. S., Shin D. M., Shulkin A., Walsh G. L., Wait J., Weill D., Waugh M. K. A., Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer Journal of the National Cancer Institute 1999 91 9 763 771 (Pubitemid 29239055)
96. Weill D., Mack M., Roth J., Swisher S., Proksch S., Merritt J., Nemunaitis J., Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection Chest 2000 118 4 966 970
97. Nemunaitis J., Swisher S. G., Timmons T., Connors D., Mack M., Doerksen L., Weill D., Wait J., Lawrence D. D., Kemp B. L., Fossella F., Glisson B. S., Hong W. K., Khuri F. R., Kurie J. M., Lee J. J., Lee J. S., Nguyen D. M., Nesbitt J. C., Perez-Soler R., Pisters K. M. W., Putnam J. B., Richli W. R., Shin D. M., Walsh G. L., Roth J., Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer Journal of Clinical Oncology 2000 18 3 609 622 (Pubitemid 30078542)
98. Swisher S. G., Roth J. A., Komaki R., Gu J., Lee J. J., Hicks M., Ro J. Y., Hong W. K., Merritt J. A., Ahrar K., Atkinson N. E., Correa A. M., Dolormente M., Dreiling L., El-Naggar A. K., Fossella F., Francisco R., Glisson B., Grammer S., Herbst R., Huaringa A., Kemp B., Khuri F. R., Kurie J. M., Liao Z., McDonnell T. J., Morice R., Morello F., Munden R., Papadimitrakopoulou V., Pisters K. M.W., Putnam Jr. J. B., Sarabia A. J., Shelton T., Stevens C., Shin D. M., Smythe W. R., Vaporciyan A. A., Walsh G. L., Yin M., Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy Clinical Cancer Research 2003 9 93 101 (Pubitemid 36109720)
99. Issaeva N., Bozko P., Enge M., Protopopova M., Verhoef L. G. G. C., Masucci M., Pramanik A., Selivanova G., Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors Nature Medicine 2004 10 12 1321 1328 (Pubitemid 40022713)
100. Selivanova G., Wiman K. G., Reactivation of mutant p53: molecular mechanisms and therapeutic potential Oncogene 2007 26 15 2243 2254 (Pubitemid 46536645)
101. Zhao C. Y., Grinkevich V. V., Nikulenkov F., Bao W., Selivanova G., Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA Cell Cycle 2010 9 9 1847 1855
102. Bykov V. J. N., Issaeva N., Shilov A., Hultcrantz M., Pugacheva E., Chumakov P., Bergman J., Wiman K. G., Selivanova G., Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound Nature Medicine 2002 8 3 282 288 (Pubitemid 34250107)
103. Bykov V. J. N., Zache N., Stridh H., Westman J., Bergman J., Selivanova G., Wiman K. G., PRIMA-1 synergizes with cisplatin to induce tumor cell apoptosis Oncogene 2005 24 21 3484 3491 (Pubitemid 40756249)
104. Magrini R., Russo D., Ottaggio L., Fronza G., Inga A., Menichini P., PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells Journal of Cellular Biochemistry 2008 104 6 2363 2373
105. Soussi T., Wiman K. G., Shaping genetic alterations in human cancer: the p53 mutation paradigm Cancer Cell 2007 12 4 303 312 (Pubitemid 47539312)
106. Vazquez A., Bond E. E., Levine A. J., Bond G. L., The genetics of the p53 pathway, apoptosis and cancer therapy Nature Reviews Drug Discovery 2008 7 12 979 98